Literature DB >> 25628777

Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells.

Longfei Huo1, Chia-Wei Li1, Tzu-Hsuan Huang1, Yung Carmen Lam1, Weiya Xia1, Chun Tu1, Wei-Chao Chang2, Jennifer L Hsu3, Dung-Fang Lee1, Lei Nie1, Hirohito Yamaguchi1, Yan Wang1, Jingyu Lang1, Long-Yuan Li2, Chung-Hsuan Chen4, Lopa Mishra5, Mien-Chie Hung3.   

Abstract

Nuclear translocation of EGFR has been shown to be important for tumor cell growth, survival, and therapeutic resistance. Previously, we detected the association of EGFR with Keap1 in the nucleus. Keap1 is a Kelch-like ECH-associated protein, which plays an important role in cellular response to chemical and oxidative stress by regulating Nrf2 protein stability and nuclear translocation. In this study, we investigate the role of EGFR in regulating Keap1/Nrf2 cascade in the nucleus and provide evidence to show that nuclear EGFR interacts with and phosphorylates nuclear Keap1 to reduce its nuclear protein level. The reduction of nuclear Keap1 consequently stabilizes nuclear Nrf2 and increases its transcriptional activity in cancer cells, which contributes to tumor cell resistance to chemotherapy.

Entities:  

Keywords:  EGFR; Keap1; Nrf2; cancer; ubiquitination

Year:  2014        PMID: 25628777      PMCID: PMC4297334     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  33 in total

Review 1.  Discovery of the negative regulator of Nrf2, Keap1: a historical overview.

Authors:  Ken Itoh; Junsei Mimura; Masayuki Yamamoto
Journal:  Antioxid Redox Signal       Date:  2010-07-13       Impact factor: 8.401

2.  Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2.

Authors:  Zheng Sun; Shirley Zhang; Jefferson Y Chan; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

3.  Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2-Cul3-Rbx1 complex to allow normal Nrf2 activation and repression.

Authors:  James W Kaspar; Suryakant K Niture; Anil K Jaiswal
Journal:  J Cell Sci       Date:  2012-02-15       Impact factor: 5.285

Review 4.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

5.  Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776.

Authors:  Yung-Luen Yu; Ruey-Hwang Chou; Chia-Han Wu; Ying-Nai Wang; Wei-Jung Chang; Yen-Ju Tseng; Wei-Chao Chang; Chien-Chen Lai; Hong-Jen Lee; Longfei Huo; Chung-Hsuan Chen; Mien-Chie Hung
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

6.  Nuclear localization of EGF receptor and its potential new role as a transcription factor.

Authors:  S Y Lin; K Makino; W Xia; A Matin; Y Wen; K Y Kwong; L Bourguignon; M C Hung
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

7.  Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.

Authors:  Xiao-Jun Wang; Zheng Sun; Nicole F Villeneuve; Shirley Zhang; Fei Zhao; Yanjie Li; Weimin Chen; Xiaofang Yi; Wenxin Zheng; Georg T Wondrak; Pak Kin Wong; Donna D Zhang
Journal:  Carcinogenesis       Date:  2008-04-15       Impact factor: 4.944

Review 8.  Oncogenic EGFR signaling networks in glioma.

Authors:  Paul H Huang; Alexander M Xu; Forest M White
Journal:  Sci Signal       Date:  2009-09-08       Impact factor: 8.192

9.  Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers.

Authors:  Tzu-Hsuan Huang; Longfei Huo; Ying-Nai Wang; Weiya Xia; Yongkun Wei; Shih-Shin Chang; Wei-Chao Chang; Yueh-Fu Fang; Chun-Te Chen; Jing-Yu Lang; Chun Tu; Yan Wang; Ming-Chuan Hsu; Hsu-Ping Kuo; How-Wen Ko; Jia Shen; Heng-Huan Lee; Pei-Chih Lee; Yun Wu; Chung-Hsuan Chen; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2013-06-10       Impact factor: 31.743

10.  Subcellular localization and cytoplasmic complex status of endogenous Keap1.

Authors:  Yoriko Watai; Akira Kobayashi; Hiroko Nagase; Mio Mizukami; Justina McEvoy; Jeffrey D Singer; Ken Itoh; Masayuki Yamamoto
Journal:  Genes Cells       Date:  2007-10       Impact factor: 1.891

View more
  11 in total

1.  Proteomic Analysis Reveals Novel Mechanisms by Which Polychlorinated Biphenyls Compromise the Liver Promoting Diet-Induced Steatohepatitis.

Authors:  Josiah E Hardesty; Banrida Wahlang; K Cameron Falkner; Hongxue Shi; Jian Jin; Yun Zhou; Daniel W Wilkey; Michael L Merchant; Corey T Watson; Wenke Feng; Andrew J Morris; Bernhard Hennig; Russell A Prough; Matthew C Cave
Journal:  J Proteome Res       Date:  2019-03-15       Impact factor: 4.466

Review 2.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

Review 3.  Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker?

Authors:  Raúl Barrera-Rodríguez
Journal:  Biomed Rep       Date:  2018-09-05

4.  Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cells.

Authors:  Kirtikar Shukla; Himangshu Sonowal; Ashish Saxena; Kota V Ramana; Satish K Srivastava
Journal:  Cancer Lett       Date:  2017-10-03       Impact factor: 8.679

Review 5.  Beyond repression of Nrf2: An update on Keap1.

Authors:  Aleksandra Kopacz; Damian Kloska; Henry Jay Forman; Alicja Jozkowicz; Anna Grochot-Przeczek
Journal:  Free Radic Biol Med       Date:  2020-03-28       Impact factor: 7.376

6.  TGF-β and Hypoxia/Reoxygenation Promote Radioresistance of A549 Lung Cancer Cells through Activation of Nrf2 and EGFR.

Authors:  Sae-lo-oom Lee; Hwani Ryu; A-rang Son; Bitna Seo; Jooyoung Kim; Seung-Youn Jung; Jie-Young Song; Sang-Gu Hwang; Jiyeon Ahn
Journal:  Oxid Med Cell Longev       Date:  2016-01-20       Impact factor: 6.543

7.  Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer.

Authors:  Ying-Hui Tong; Bo Zhang; You-You Yan; Yun Fan; Jia-Wen Yu; Si-Si Kong; Dan Zhang; Luo Fang; Dan Su; Neng-Ming Lin
Journal:  Oncotarget       Date:  2017-07-11

8.  GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers.

Authors:  How-Wen Ko; Heng-Huan Lee; Longfei Huo; Weiya Xia; Cheng-Chieh Yang; Jennifer L Hsu; Long-Yuan Li; Chien-Chen Lai; Li-Chuan Chan; Chien-Chia Cheng; Adam M Labaff; Hsin-Wei Liao; Seung-Oe Lim; Chia-Wei Li; Yongkun Wei; Lei Nie; Hirohito Yamaguchi; Mien-Chie Hung
Journal:  Oncotarget       Date:  2016-08-30

9.  Revealing the subtyping of non-small cell lung cancer based on genomic evolutionary patterns by multi-region sequencing.

Authors:  Gaoming Liao; Xin Liang; Yanyan Ping; Yong Zhang; Jianlong Liao; Yihan Wang; Xiaobo Hou; Zedong Jiang; Xiaoqiu Dong; Chaohan Xu; Yun Xiao
Journal:  Cancer Med       Date:  2020-10-20       Impact factor: 4.452

Review 10.  Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies.

Authors:  Anna Maria Mileo; Stefania Miccadei
Journal:  Oxid Med Cell Longev       Date:  2015-11-16       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.